Literature DB >> 28224433

Association of HLA alleles (A, B, DRB1) and HIV-1 infection in the Han population of Hubei, China.

Wang-Xia Li1, Jia-An Xia2, Xia Zhou2, Yan Ma3, Gang Shen3, Feng-Wu Qiu3.   

Abstract

The HIV susceptibility and resistance alleles in the HLA genes were determined by investigating the distribution characteristics of the HLA alleles (A, B, and DRB1) in HIV-infected individuals of the Han population in Hubei, and by comparing these alleles with HIV-negative individuals from the same area. A cohort of 424 HIV-1 infected individuals were chosen as study subjects, and 836 HIV-negative healthy subjects from the same area served as the control population. HLA-A, B, and DRB1 allele typing was performed using polymerase chain reaction-sequence-specific oligonucleotide probes (PCR-SSOP) and polymerase chain reaction-sequencing based typing (PCR-SBT) techniques. Arlequin ver3.0 was used to analyze the allele and haplotype frequencies of HLA-A, B, and DRB 1, whereas Epi Info 7 and SPSS18.0 was used to analyze the differences in the HLA alleles between the HIV-1 positive and HIV-1 negative groups. A*02:03, DRB1*01:01, and DRB1*15:01 alleles and their haplotypes as well as the HLA_Bw4-Bw6 hybrid showed a protective effect on HIV-1 infection. After adjusting for confounding factors such as age and sex, multivariate logistic regression analysis revealed that B*15:02G, DRB1*01:01, and DRB1*15:01 subtypes were the resistance genes of HIV-1 infection, while B*13:01 might increase susceptibility to HIV-1 infection. The correlation between A*02:06 and B*15:01G subtypes and HIV-1 susceptibility was independent of the age and sex of the host. This study demonstrated the influence of genetic factors in humans such as HLA polymorphism on individuals to resist HIV-1 infection. Association studies of HLA polymorphism, susceptibility/resistance to HIV-1 infection, and hosts' genetic background are of significant importance for research on HIV-1 pathogenesis and vaccine design.

Entities:  

Keywords:  China; allele; human immunodeficiency virus; human leukocyte antigen; resistance genes; susceptibility gene

Mesh:

Substances:

Year:  2017        PMID: 28224433     DOI: 10.1007/s11596-017-1706-z

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  13 in total

1.  Molecular typing for HLA class I using ARMS-PCR: further developments following the 12th International Histocompatibility Workshop.

Authors:  S Tonks; S G Marsh; M Bunce; J G Bodmer
Journal:  Tissue Antigens       Date:  1999-02

2.  Association of human leukocyte antigen-A11 with resistance and B40 and DR2 with susceptibility to HIV-1 infection in south India.

Authors:  Paramasivam Selvaraj; Soumya Swaminathan; Kalichamy Alagarasu; Sampathkumar Raghavan; Gopalan Narendran; Paramjir Narayanan
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

3.  Functional supertype of HLA-A2 in the presentation of Flu matrix p58-66 to induce CD8+ T-cell response in a Northern Chinese population.

Authors:  H-G Zhang; X-W Pang; X-Y Shang; Q Xing; W-F Chen
Journal:  Tissue Antigens       Date:  2003-10

Review 4.  [Genome-wide association study on complex diseases: study design and genetic markers].

Authors:  Wei-Li Yan
Journal:  Yi Chuan       Date:  2008-04

5.  Roles of the six peptide-binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones.

Authors:  M Matsui; C E Hioe; J A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

Review 6.  HLA-A2 polymorphism and immune functions.

Authors:  P Krausa; M J Browning
Journal:  Eur J Immunogenet       Date:  1996-08

7.  Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

Authors:  Maureen P Martin; Ying Qi; Xiaojiang Gao; Eriko Yamada; Jeffrey N Martin; Florencia Pereyra; Sara Colombo; Elizabeth E Brown; W Lesley Shupert; John Phair; James J Goedert; Susan Buchbinder; Gregory D Kirk; Amalio Telenti; Mark Connors; Stephen J O'Brien; Bruce D Walker; Peter Parham; Steven G Deeks; Daniel W McVicar; Mary Carrington
Journal:  Nat Genet       Date:  2007-05-13       Impact factor: 38.330

8.  Disparate associations of HLA class I markers with HIV-1 acquisition and control of viremia in an African population.

Authors:  Wei Song; Dongning He; Ilene Brill; Rakhi Malhotra; Joseph Mulenga; Susan Allen; Eric Hunter; Jianming Tang; Richard A Kaslow
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

9.  Arlequin (version 3.0): an integrated software package for population genetics data analysis.

Authors:  Laurent Excoffier; Guillaume Laval; Stefan Schneider
Journal:  Evol Bioinform Online       Date:  2007-02-23       Impact factor: 1.625

10.  HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.

Authors:  Marcus Altfeld; Elizabeth T Kalife; Ying Qi; Hendrik Streeck; Mathias Lichterfeld; Mary N Johnston; Nicole Burgett; Martha E Swartz; Amy Yang; Galit Alter; Xu G Yu; Angela Meier; Juergen K Rockstroh; Todd M Allen; Heiko Jessen; Eric S Rosenberg; Mary Carrington; Bruce D Walker
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

View more
  2 in total

1.  T Cell Therapy Targeted on HLA-A02 Restricted HIV Antigen Epitopes: An Open Label Cellular Therapy Trial Using CD8+ T Cell.

Authors:  Sai Liu; Jianping Sun; Zhen Li; Ling Qin; Guihai Liu; Kang Li; Hao Wu; Tao Dong; Yonghong Zhang
Journal:  Front Immunol       Date:  2019-03-18       Impact factor: 7.561

2.  HLA-B*13, B*35 and B*39 Alleles Are Closely Associated With the Lack of Response to ART in HIV Infection: A Cohort Study in a Population of Northern Brazil.

Authors:  Leonn Mendes Soares Pereira; Eliane Dos Santos França; Iran Barros Costa; Erika Vanessa Oliveira Jorge; Patrícia Jeanne de Souza Mendonça Mattos; Amaury Bentes Cunha Freire; Francisco Lúzio de Paula Ramos; Talita Antonia Furtado Monteiro; Olinda Macedo; Rita Catarina Medeiros Sousa; Eduardo José Melo Dos Santos; Felipe Bonfim Freitas; Igor Brasil Costa; Antonio Carlos Rosário Vallinoto
Journal:  Front Immunol       Date:  2022-03-16       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.